ReceptorPharma Inc Alternatives & Competitors

12 companies similar to ReceptorPharma Inc — Do something of consequent to help the world. Proactively including the scientif...

Satori Pharmaceuticals

Pioneering advanced therapies for Alzheimer's, Parkinson's, and other neurodegenerative di...

Venture round $47.32M

Health Care Pharmaceutical

Dicerna Pharmaceuticals

Pioneering breakthroughs in genetic disorders and liver diseases using RNA interference te...

201-500 Post-IPO Equity $420.45M

Biotechnology Health Care +1

AlphaMol Science Ltd

GPCR Drug Discovery Innovator.

3 Series A

Biopharma Biotechnology +1

Alector

We are on a mission to make brain disorders history.

141 IPO $495.50M

South San Francisco, Unit...

Biotechnology Health Care +2

Track all ReceptorPharma Inc competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Senexis Limited

Small-molecule therapies targeting amyloid protein toxicity

3 $4.30M

Cambridge, United Kingdom

Biotechnology Life Sciences +1

Cerevance

Cerevance a neuroscience company

35 Series C $224.00M

Boston, United States

Biotechnology Health and Wellness +2

Elixir Pharmaceuticals

Pioneering the future of metabolic disease treatment by harnessing genetic interactions to...

Series D $98.50M

Biotechnology Pharmaceutical

CV6 Therapeutics, (NI) Ltd.

CV6 Therapeutics is dedicated to improving patients lives through the development of novel...

11 Venture round $8.00M

United Kingdom

Biotechnology Health Care +1

Alzprotect SAS

Therapeutic Solutions for Neurodegeneration

12 Grant $16.34M

Loos, France

Biotechnology Pharmaceutical

Galimedix Therapeutics, Inc.

Developing novel neuroprotective drugs to treat the leading causes of blindness and Alzhei...

7 Seed

United States

Health and Wellness Pharmaceutical

Aria Pharmaceuticals

Aria Pharmaceuticals is a preclinical-stage pharmaceutical company discovering and develop...

4 Series B $14.30M

Palo Alto, United States

AI Big Data +3

Accera

Pioneering breakthroughs in neurodegenerative therapies for Alzheimer’s, Parkinson’s, and...

11-50 Venture round $196.22M

Biotechnology Health Care +1

About ReceptorPharma Inc

ReceptorPharma Inc is a pharmaceutical startup founded in 2017 with a mission to develop new Alzheimer’s drugs through a novel pathway and mechanism. Utilizing the latest research on disease-coupled genes and a well-studied drug target protein family, the company aims to create a new generation of Alzheimer’s disease d...

Business keywords

Alzheimer's Disease, Drug Discovery, Pharmaceuticals, Genetic Research, Drug Targeting, Neurodegenerative Diseases, Cancer Treatment, Novel Pathway, Competitive Advantage

Frequently Asked Questions

Companies similar to ReceptorPharma Inc include Satori Pharmaceuticals, Dicerna Pharmaceuticals, AlphaMol Science Ltd, Alector, Senexis Limited. They work in Pharmaceutical and share ReceptorPharma Inc's focus on neurodegenerative diseases, pharmaceuticals and drug discovery.

Bounce Watch lists 12 companies that share ReceptorPharma Inc's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches ReceptorPharma Inc and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

ReceptorPharma Inc Profile Satori Pharmaceuticals Alternatives Dicerna Pharmaceuticals Alternatives AlphaMol Science Ltd Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at ReceptorPharma Inc on 12 Sep 2024. The 12 companies listed here were last checked between 21 Jun 2024 and 16 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.